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Abstract: Antibiotics are the elective drugs in bovine mastitis (BM) treatment, despite their low
rates of efficiency and effectiveness and increasing risk of pathogen resistance. In this sense, it
is urgent to discover new and effective antimicrobial agents to apply in BM control and even
treatment. Plant extracts have been widely recognized as a rich source of phytochemicals with
antimicrobial potential. Thus, the present work aims to compare the bioactivity of Eucalyptus globulus
and Juglans regia extracts against Staphylococcus aureus bovine mastitis strains with penicillin G. At
non-toxic concentrations, E. globulus exerted a bacteriostatic effect in planktonic cells and J. regia had
no antimicrobial activity. Penicillin G, at minimum inhibitory concentration (MIC), demonstrated
bactericidal activity, but just for S. aureus 3, 5, 6 and ATCC 25923, while the other strains seem to have
acquired resistance. On the other hand, E. globulus and penicillin G in combination demonstrated
synergy, being the most effective approach against S. aureus 1, 2 and 4. Thus, penicillin alone
and in combination with E. globulus or J. regia seems to be promissory strategies to control bovine
mastitis infections.
Keywords: bovine mastitis; Eucalyptus globulus Labill.; Juglans regia L.; penicillin G;
Staphylococcus aureus
1. Introduction
Bovine mastitis (BM) is one of the most problematic infectious disorders with considerable
economic losses for the dairy industry [1]. Antimicrobial agents, particularly antibiotics, have been
widely used for the management and treatment of BM [2]. However, this kind of therapy has
markedly promoted the emergence of antibiotic-resistant species, hampering mastitis management [1].
Staphylococcus aureus (S. aureus) is one of the most problematic causative agents of BM, being even
recently highlighted by several studies that S. aureus contaminated milk from mastitis’ infected animals
can enter in the dairy production chain and be the origin of food contamination [3–5]. Therefore, the
search for natural and effective antimicrobial drugs for preventive and therapeutic purposes of BM
is an urgent need. Natural matrices are rich sources of a great variety of useful bioactive molecules
for the development of new antimicrobial products [6]. As an example, Eucalyptus globulus Labill.,
rich in volatile compounds, is a well-known medicinal plant due to its biological and pharmacological
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properties [7–9]. E. globulus essential oil has a great application in folk medicine for the treatment of
several diseases, including mastitis [10]. On the other hand, leaves of Juglans regia L. are also widely
used as antimicrobial in complementary and alternative therapies [11,12].
Nowadays, several research groups are testing fractions and even extracts from J. regia in animal
models with different pathologies aiming to find potential therapeutic benefits [11]. Adnan et al.
(2018) suggested that the antimicrobial activity of plants is primarily due to the presence of phenolic
compounds [13], and therefore the higher the extraction of phenolic compounds the greater the
antimicrobial efficacy. Moreover, although alcoholic solvents such as methanol and ethanol are
preferentially used in plant extractions it was shown that phenolic extraction is significantly improved
when a small portion of water is added to organic solvents [14].
Considering their promisor antimicrobial properties [15] and aiming to overcome the problem
of antibiotic resistance, in this work the antibacterial activity of Eucalyptus globulus and Juglans regia
methanol–water extracts were compared with penicillin G, alone and in combination, against S. aureus
isolated from cows suffering mastitis. The evaluation of the cytotoxic potential of E. globulus and J. regia
extracts were also performed.
2. Results
Table 1 shows the minimum inhibitory concentration (MIC) values for penicillin G. From the
total BM isolates, three of them (i.e., S. aureus 1, 2 and 4 strains) presented an MIC value of 24 µg/mL,
while the remaining ones, including S. aureus reference strain ATCC 25923, presented an MIC value of
0.4 µg/mL (Table 1).
Table 1. Minimum inhibitory concentration (MIC) of penicillin G against S. aureus isolates (n = 7),
determined by the broth microdilution method.
MIC (µg/mL)
Strains S. aureus1
S. aureus
2
S. aureus
3
S. aureus
4
S. aureus
5
S. aureus
6
S. aureus ATCC
25923
Pen G 24 24 0.4 24 0.4 0.4 0.4
Pen G: Penicillin G.
The MIC values obtained for penicillin G demonstrated that S. aureus 1, 2 and 4 strains present
a similar level of susceptibility, while S. aureus 3, 5, 6 and S. aureus ATCC 25923 may be included in
another group of susceptible strains. Therefore, based on their resistance patterns it was possible to
divide the tested strains into two distinct groups, i.e., most resistant (S. aureus 1, 2 and 4) and less
resistant (S. aureus ATCC 25923, 3, 5 and 6).
In order to know which concentrations of plant extracts to use in this study, the cytotoxicity of
E. globulus and J. regia was evaluated. The percentage of viable animal cells obtained after exposure
to both plant extracts was closely related to those of the negative control (cells grown without plant
extracts), at concentrations ≤100 µg/mL of E. globulus (Figure 1a) and ≤195 µg/mL of J. regia (Figure 1b)
extracts (p > 0.05). Specifically, for the E. globulus extract, at a concentration of 195 µg/mL, the
percentage of viable cells (63.9%) was close to the limit to be considered non-cytotoxic (70%) based on
ISO 10993-5:2006. Considering the results obtained, the antibacterial activity of E. globulus and J. regia
(at non-cytotoxic concentrations) and penicillin G (at MIC) was tested alone and in combination against
planktonic cells of S. aureus. Moreover, based on the MIC pattern of results, only a representative strain
from each group was selected to be presented in Figure 2, namely S. aureus 1 and S. aureus ATCC 25923.
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Figure 1. Fibroblast 3T3 viability after 24 h of contact with different concentrations of E. globulus (a)
and J. regia ( ) extracts, eas re it assay. The negative control allowed the perfect growth of
the cells (cells grown without extracts; 100% viability). * p < 0.05.
The use of E. globulus alone seems to exert a bacteriostatic effect against S. aureus until 8 h of
incubation (Figure 2). Over time, E. globulus and J. regia alone presented a slight inhibitory effect, when
compared with the positive control (Figure 2). Regarding penicillin G, no bioactivity was observed
against S. aureus 1, 2 and 4 (Figure 2a), with only bactericidal effects being evident against all the other
strains selected (Figure 2b). In this case, penicillin G promoted a log reduction ranging from 2.78 to
5.76, after 24 h (p < 0.05). On the other hand, when both extracts were combined with penicillin G,
the most effective antimicrobial activity was observed for S. aureus 1, 2 and 4 strains, compared to the
antimicrobial agent tested alone (Figure 2a).
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Figure 2. Colony forming units (CFUs) of Staphylococcus aureus 1 (a) and ATCC 25923 (b), cultured
within methanol–water extract of E. globulus (100 µg/mL), J. egia (195 µg/mL) and penicillin G (MIC),
alone and in combination. C+ - Positive control. * p < 0.05.
3. Discussion
Penicillin is the most commonly used drug in the treatment of BM, even though their use is closely
related to the increasing appearance of resistant strains [16]. In this sense, the assessment of the
feasibility of using a combinatory strategy might provide considerable benefits, even allowing a
greater efficacy (synergistic or potentiation reaction) at lower doses, reducing the development of
drug-resistant species and even preventing the occurrence of side effects [17]. Thus, the evaluation
of the antimicrobial activity of both plant extracts against planktonic cells of S. aureus BM isolates
and S. aureus ATCC 25923 were performed under different conditions, which included: The use of
E. globulus and J. regia alone and in combination, at non-cytotoxic concentrations; and the use of
penicillin G at MIC value, alone and in combination with both plant extracts.
Then, the assessment of the cytotoxic potential and safety of both extracts was performed, and the
results obtained for both matrices revealed that E. globulus and J. regia are non-toxic to animal cells
at concentrations ≤100 and ≤195 µg/mL, respectively (Figure 1a,b). When both extracts were used
at non-cytotoxic concentrations and compared with the antibacterial effect exerted by penicillin G,
the most prominent effect was observed to E. globulus extract against S. aureus 1, 2 and 4 strains
(Figure 2a). For those strains, E. globulus evidenced a bacteriostatic effect until 8 hours of incubation.
On the other hand, no antimicrobial effects were observed with penicillin G. In fact, although E. globulus
exerted a similar bacteriostatic effect against the remaining strains, penicillin G was the most effective
agent, even exerting bactericidal effects (Figure 2b). Moreover, the obtained penicillin G MIC value to
S. aureus 1, 2 and 4 strains was nearly 60 times higher than those obtained with S. aureus 3, 5, 6 and
ATCC 25923 (Table 1), being, therefore, more resistant to penicillin G.
Synergistic effects were observed to S. aureus 1, 2 and 4 strains to the combinations E. globulus
+ penicillin G and J. regia + penicillin G being first the most effective combination. However,
the combination of these agents with J. regia did not further improve their antimicrobial activity.
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For these strains, plant extracts combined with penicillin G seemed to exert an immediate antimicrobial
effect and the number of colony forming units (CFUs) decreased dramatically up to 8 h. However,
CFUs increased after 24 h incubation under the combination strategy (Figure 2a). Perhaps a new dose
of plant extracts will necessarily be added after 6/8 h of treatment in order to obtain a higher and
prolonged inhibitory activity. Concerning the S. aureus ATCC 25923, 3, 5 and 6 strains, penicillin G
used alone still continued to be more effective than all the combinations tested. Moreover, penicillin G
in combination with plant extracts promoted, over time and up to 24 h of incubation, an increasing
CFU log reduction probably due to the bactericidal effect of penicillin G (Figure 2b).
In general, this study revealed an interesting synergy of E. globulus or J. regia in combination with
penicillin G for most penicillin-resistant strains. Penicillin G is a β-lactam antibiotic that inhibits cell
wall synthesis. On the other side, the major phenolic compounds found in E. globulus extract belong to
the phenolic acids (gallic acid, caffeic acid and ellagic acid) and the flavonoids (quercetin) group [15].
Specifically, the most common phenolic compounds found in E. globulus and J. regia extracts are caffeic
acid derivatives and quercetin. When looking at the specific mechanisms of action, gallic and caffeic
acids mainly inhibit the H+-ATPase, responsible for ATP production [18] The ellagic acid interacts with
enzymes, consequently inhibiting their interaction with proteins [18]. Flavonoids affect the cell wall
stability, promoting the disruption of cell structure [18]. Thus, the major phenolic compounds found in
E. globulus and J. regia, gallic acid and quercetin derivatives, respectively, demonstrated a great ability
to strengthen the bioactivity of β-lactam antibiotics by inhibiting the penicillin binding protein 2a
(PBP2a) [19]. This peptidoglycan transpeptidase, in cooperation with the transglucosylase domain of
PBP2 of S. aureus, is responsible for bacterial proliferation when exposed to β-lactam antibiotics [20].
Therefore, PBP2a inhibitors are usually used to overcome the antibiotics resistance and it is probably
the mechanism responsible for the synergy observed when antimicrobials combination was tested.
It is also interesting to highlight that, to the most susceptible strains, penicillin G is still the
most effective approach. Moreover, it should be also pointed out that, in vitro studies might not
reflect what really occurs in vivo. In fact, during administration, natural molecules suffer numerous
biochemical reactions in organisms while some others need to be metabolized to become biologically
active, and other become inactive [21]. Furthermore, the in vivo bioavailability of antimicrobial drugs
may vary both due to endogenous factors and even inter and intra-individual variations.
4. Materials and Methods
4.1. Samples
In this study, the leaves of two plant species were used: Eucalyptus globulus Labill. (blue gum)
from commercial origin (Cantinho das Aromáticas, an organic and certified farm from Vila Nova de
Gaia, Portugal), and Juglans regia L. (walnut) harvested in Trás-os-Montes, Bragança, Portugal, collected
and identified according to Santos et al. [12].
4.2. Standards and Reagents
Methanol was of analytical grade purity and supplied by Pronalab (Lisbon, Portugal). Tryptic Soy
Broth (TSB) medium and Tryptic Soy Agar (TSA) were purchased from Liofilchem (Roseto degli Abruzzi,
Italy) and Merck (Darmstadt, Germany), respectively, and prepared according to the manufacturer’s
instructions. Water was treated in a Milli-Q water purification system (TGI Pure Water Systems,
Greenville, SC, USA). Penicillin G was purchased from Sigma Chemical Co., (St. Louis, MO, USA).
4.3. Preparation of the Extracts
Methanol–water extracts were obtained by extracting each plant sample (1 g) with 30 mL of
methanol–water (80:20, v/v) at 25 ◦C and 150 rpm for 1 h, and filtering through Whatman No. 4 paper.
The final residue was then extracted with an additional 30 mL portion of methanol–water mixture.
Each one of the combined extracts was evaporated at 35 ◦C under reduced pressure (rotary evaporator
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Büchi R-210, Flawil, Switzerland) and then lyophilized (FreeZone 4.5, Labconco, Kansas City, MO,
USA). The lyophilized methanol–water extracts were re-dissolved in water to obtain stock solutions
at 50 × 103 µg/mL, from which several dilutions were prepared. E. globulus extract was previously
characterized in terms of chemical compounds [12,15,22], and J. regia (methanolic and aqueous extracts)
was previously characterized by Santos et al. [12].
4.4. Determination of Minimal Inhibitory Concentrations (MICs)
Seven S. aureus were selected for this work: Reference strain (S. aureus ATCC 25923) and
six BM isolates, kindly provided by the Portuguese lab (Segalab-Laboratório de Sanidade Animal e
Segurança Alimentar SA). Minimal inhibitory concentration (MIC) of penicillin G was determined
by the microbroth dilution technique. The determination of MIC values was performed by the serial
two-fold dilutions method at concentrations ranging from 2 × 10−2 µg/mL to 24 µg/mL. The final
cell concentration used was 5 × 105 cells/mL. Then, 96-well plates (Orange Scientific, Braine-l’Alleud,
Belgium) were incubated at 37 ◦C for 24 h. Samples (cells grown with penicillin G) and bacteria-free
controls (positive controls) were also included. After visualization of the resultant plate, MIC values
were correspondent to the antibiotic concentration where there was no visible growth, or even
bacteriostatic effect by comparison with the positive controls. The number of viable cells was assessed
through determination of a number of colonies forming units (CFUs), after 24 h of incubation at 37 ◦C.
The results were presented as total of CFUs (Log CFUs). All the experiments were carried out in
triplicate and repeated at three different moments.
4.5. Cytotoxicity Assay
The effect of E. globulus and J. regia on cell viability was assessed by the MTS ((3-[4,5-
carboxymethoxyphenyl]-2-(4-sulfophenyl)-2H-tetrazolium), Promega) assay, using human primary
fibroblast cell lines (3T3-CCL 163-from the American Type Culture Collection). Briefly, the cells were
trypsinized and seeded in 96-well plates at a final concentration of 1 × 105 cells/mL, in Dulbecco
Modified Eagle Medium (DMEM, Biochrom GmbH) supplemented with 10% of fetal bovine serum
(FBS, Sigma Aldrich) and 1% of penicillin/streptomycin (Biochrom AG), at 37 ◦C and 5% CO2. After
24 h of incubation, the cell cultures were treated with several concentrations of E. globulus and J. regia
dissolved in DMEM complete medium, for a further 24 h. After this time, the wells were washed twice
with phosphate buffered saline (PBS) (1×), and then 150 µL of MTS with DMEM without phenol (1/10,
v/v) (Sigma Aldrich) were added to each well. After 1 h, the cell viability was assessed by reading the
absorbance at 490 nm (absorbance of the orange formazan product) in a microplate reader Sunrise
(Männdorf, Switzerland). The results were expressed as a % of viable cells, corresponding the OD490 to
cells grown without extracts as 100% of cell viability. Dimethyl sulfoxide (DMSO, Sigma Aldrich) at
50% (v/v) in DMEM was used as positive control.
4.6. S. aureus Susceptibility to Eucalyptus globulus, Juglans regia and Penicillin G
The antibacterial activity of E. globulus (100 µg/mL) and J. regia (195 µg/mL) in planktonic cells
was tested against seven different S. aureus strains: One reference strain (S. aureus ATCC 25923) and
six clinical isolates (S. aureus 1, 2, 3, 4, 5 and 6). For that, strains (1 × 106 cells/mL) were grown in
Erlenmeyer flasks in the presence of each selected plant extract, alone and in combination. Then,
the cells were incubated at 37 ◦C and 120 rpm for 24 h. The surviving viable bacteria were obtained
by CFU assay after 0, 2, 4, 6, 8 and 24 h of incubation. The antimicrobial activity of selected plant
extracts was compared with the effect of penicillin G at determined MIC concentration, following the
same procedure. Antibacterial activity of penicillin G alone and in combination with E. globulus and
J. regia was also tested. A synergistic effect was considered when the bioactivity of the antimicrobials
in combination was higher than the sum of the effect of each agent alone [23]. All experiments were
performed in triplicate and repeated on three different occasions.
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4.7. Statistical Analysis
Data were analyzed using one-way analysis of variance (ANOVA) and means were compared
using Tukey’s honestly significant difference (HSD) multiple comparisons test. All statistical tests were
performed using the Prism software package (GraphPad Software version 6.0 for Macintosh). Results
were considered statistically significant when p < 0.05.
5. Conclusions
In overall, this study highlighted the problem of emerging resistant species to antimicrobial agents.
In fact, penicillin G, one of the main therapeutic strategies used in the prevention and treatment of
BM, seemed to be ineffective against planktonic cells of the most resistant strains (50% of the tested
isolates). On the other hand, non-cytotoxic concentrations of E. globulus exerted a bacteriostatic effect.
Moreover, depending on the level of resistance evidenced by S. aureus strains to penicillin G, penicillin
alone and in combination with E. globulus and/or J. regia seems to be promissory strategies to control
bovine mastitis infections. In this sense, this study drew attention to a worrying problem concerning
BM and evidenced the clear and urgent need to discover effective therapeutic strategies to control and
to manage this pathology.
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